704 related articles for article (PubMed ID: 15248111)
1. [Current diagnosis and therapy of esophageal carcinoma].
Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
3. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
4. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
[TBL] [Abstract][Full Text] [Related]
5. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
Barthel JS; Kucera ST; Lin JL; Hoffe SE; Strosberg JR; Ahmed I; Dilling TJ; Stevens CW
Gastrointest Endosc; 2010 Feb; 71(2):235-40. PubMed ID: 20003971
[TBL] [Abstract][Full Text] [Related]
6. [Esophageal carcinoma -- current status in diagnosis and therapy].
Baumhoer D; Ramadori G
Z Gastroenterol; 2005 Apr; 43(4):399-409. PubMed ID: 15830307
[TBL] [Abstract][Full Text] [Related]
7. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
8. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
9. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
Prenzel KL; König A; Schneider PM; Schnickmann C; Baldus SE; Schröder W; Bollschweiler E; Dienes HP; Mueller RP; Izbicki JR; Hölscher AH
Ann Surg Oncol; 2007 Feb; 14(2):954-9. PubMed ID: 17103071
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic strategies for advanced respectable esophageal cancer].
Kitagawa Y
Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):333-7. PubMed ID: 19068714
[TBL] [Abstract][Full Text] [Related]
11. Preoperative chemotherapy and radiotherapy for esophageal carcinoma.
Naunheim KS; Petruska P; Roy TS; Andrus CH; Johnson FE; Schlueter JM; Baue AE
J Thorac Cardiovasc Surg; 1992 May; 103(5):887-93; discussion 893-5. PubMed ID: 1569771
[TBL] [Abstract][Full Text] [Related]
12. Management of advanced-stage operable esophageal cancer.
Bharat A; Crabtree T
Surg Clin North Am; 2012 Oct; 92(5):1179-97. PubMed ID: 23026277
[TBL] [Abstract][Full Text] [Related]
13. Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus.
Donington JS; Miller DL; Allen MS; Deschamps C; Nichols FC; Pairolero PC
Ann Thorac Surg; 2004 Apr; 77(4):1193-8; discussion 1198-9. PubMed ID: 15063233
[TBL] [Abstract][Full Text] [Related]
14. Management of esophageal adenocarcinoma.
Tougeron D; Richer JP; Silvain C
J Visc Surg; 2011 Jun; 148(3):e161-70. PubMed ID: 21715236
[TBL] [Abstract][Full Text] [Related]
15. Treatment of locally advanced esophageal cancer with surgery and chemoradiation.
Siersema PD; van Hillegersberg R
Curr Opin Gastroenterol; 2008 Jul; 24(4):535-40. PubMed ID: 18622172
[TBL] [Abstract][Full Text] [Related]
16. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
19. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
González Ortiz DI; Toro DH
Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
